Strain Name: |
NZO/HlLtJ |
|---|---|
Stock Number: |
002105 |
Availability: | Contact Customer Service for more information. |
General Terms and Conditions |
| Former Name |
NZO/HILtJ (Changed: 24-OCT-07
) |
|
NZO/HlJ (Changed: 15-DEC-04
) | |
| Strain Common Names | New Zealand Obese; |
| Genes & Alleles | Pctp; PctpR120H; |
Type Inbred Strain Additional information on Inbred Strains. Mating System Sibling x Sibling (Female x Male) Species laboratory mouse H2 Haplotype z Generation ?+F39 (05-DEC-07) Appearance
agouti
Related Genotype: A/AStrain Description
NZO mice of both sexes exhibit high birth weights and are significantly heavier at weaning age, Severe obesity (including both visceral and subcuatneous fat depots) develops even when mice are maintained on a standard diet containing 4.5% fat. Both males and females of the NZO/Hl substrain exhibit impaired glucose tolerance (IGT), but subsequent type 2 maturity onset (NIDDM) diabetes development is limited to males, with a phenotype penetrance of 50% or less. NZO/Hl mice also show anti-insulin receptor antibodies, a defect in leptin transport, and hypertension. The genetic lesion appears to be within the islets of Langerhans as transfer of pancreatic islets from normal mice returns body weights and blood glucose levels to within normal range. Ovarian granulosa cell tumors, lymphomas, duodenal, and lung tumors have also been noted to occur in NZO mice at an elevated frequency. F1 hybrids of NON/Lt and NZO/Hl provide a new model of obesity-induced diabetes. Male (NON/Lt x NZO/Hl)F1 hybrids are obese (BW = 53.5 g by 16 wks) and almost all develop maturity onset NIDDM. F1 males on a 4% diet will develop hyperglycemia around 20 to 24 weeks of age; increasing the fat content of the diet accelerates diabetes onset to 16 to 20 wks of age. (NZO/Hl x NON/Lt)F1 hybrids will develop diabetes slightly faster than their reciprocal cross due to the NZO maternal environment; however this cross is difficult to produce due to the inherently poor breeding performance of NZO/HlJ female mice. F1 females exhibit a weight gain similar to the NZO parent, and have impaired glucose tolerance but are resistant to diabetes development. Diabetes development can be accelerated to 8-12 weeks by fostering onto an F1 dam. Reciprocal backcrosses to the parental strains and analysis of (NON/Lt x NZO/Hl)F2 mice has led to the identification of a number of complex diabetes-predisposing ("diabesity") QTLs. Dr. Leiter's research group at The Jackson Laboratory is currently developing a series of 9 recombinant congenic strains (RCS) made by backcrossing the (NZO/Hl x NON/Lt)F1 for two generations onto the NON/Lt background before inbreeding (~12% NZO/Hl, 88% NON/Lt genomes). Preliminary analysis indicates that body weight gains of all RCS are higher than NON/Lt, but none are as obese as NZO/Hl; some of these RCS develop NIDDM while others are resistant. These new strains will be useful to further analyze diabesity QTLs and as new models for type 2 (NIDDM) diabetes. An additional benefit of the RCS is better breeding performance than NZO/Hl.Strain Development
The New Zealand Obese (NZO) inbred mouse strain was initially selected for polygenic obesity. NZO mice share a common origin with New Zealand Black mice (NZB). M. Bielschowsky began inbreeding of outbred mice obtained from the Imp. Cancer Research Fund, London began at the University of Otago Medical School in 1948.
Mammalian Phenotype Terms assigned by genotype |
| Allele Symbol | PctpR120H | ||
|---|---|---|---|
| Allele Name | R120H | ||
| Strain of Origin | NZO | ||
| Gene Symbol and Name | Pctp, phosphatidylcholine transfer protein | ||
| Chromosome | 11 | ||
| Gene Common Name(s) | PC-TP; STARD2; | ||
| Molecular Note | A G to A transition in exon 4 resulted in the arginine to histidine substitution at amino acid 120 in NZO, NZB/BINJ and NZW/LacJ strains. This mutation rendered the protein was inactive. [MGI Ref ID J:114974] | ||
| Diet Information | LabDiet® 5K54 |
|---|
View Strains carrying PctpR120H (2 strains)
Strains carrying other alleles of Pctp
006607 B6.129-Pctptm1Bor/J View Strains carrying other alleles of Pctp (1 strain)
Mouse Phenome Database
Festing Inbred Strain Characteristics: NZO
Genetic Quality Control Annual Report
JAX® NOTES, Fall 2002; 487. New Polygenic Obesity Mouse Models.
JAX® NOTES, Winter 2006; 504. JAX? Mice Strain Sleeps While Standing.
Diabetes and Obesity Research
Hyperglycemia (males)
Hyperinsulinemia (males)
Insulin Resistance (males)
Obesity With Diabetes (severe)
Type 2 Diabetes (NIDDM) (males)
Reproductive Biology Research
Fertility Defects
Gonadal Tumors (granulosa cell tumors)
| Strain Name: | NZO/HlLtJ |
| Stock Number: | 002105 |
This strain is currently Contact Customer Service for more information..
To register your interest in this strain go to the Strain Interest Form.
Estimated Available for Sale Date:
Please note: Estimated available for sale dates are provided to keep customers better informed on strains under development. Please note that our Colony Managers routinely monitor the target date and edit it based on breeding performance and other factors. The length of time it takes to make a new strain available for sale depends on genotype, age, number of animals sent by the Donating Investigator, breeding performance, additional strain development (backcrossing, making homozygous), and anticipated demand for the strain/interest registered.
View All Strains Under Development
| Standard Supply | Contact Customer Service for more information. |
|---|---|
| Supply Notes |
Usually shipped between four and six weeks of age. This strain is included in the Mouse Mutant Resource collection. Genomic DNA is available for this strain from the Mouse DNA Resource. |
| Licensing | See General Terms and Conditions below |
Purchasing Information
JAX® Mice Orders
Surgical Services
Contact Information
Orders & Technical Support
Tel: 800.422.6423 or 207.288.5845
Fax: 207.288.6150
Technical Support Email Form